Matches in SemOpenAlex for { <https://semopenalex.org/work/W6570133> ?p ?o ?g. }
- W6570133 abstract "Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the western world, and continues to have very low cure rates. The bulk of the tumour cells are non-cycling peripheral cells that accumulate from a minority of dividing cells within proliferation centres (PCs), located the lymph nodes (LN) and spleen. The PCs are rich in activated T helper (TH) cells that express CD40L and secrete IL-4. Like normal B cells, CLL cells interact with TH via their expression of CD40 and receive signals from IL4. This stimulation provides the signal for B cells to divide, as well as protecting them from apoptotic stimuli. Consequently, many current therapies are unable to sufficiently target the cells in the PC, resulting in therapy resistance, residual disease (RD) and relapse. In addition, most therapies have associated toxicities, restricting their use to younger, fitter patients. Thus, there is an urgent need for new therapies with low toxicity, especially for older patients. New drug discovery is time consuming and expensive. Redeployment of existing drugs is one way to potentially combat this issue. The lipid lowering drug Bezafibrate (BEZ) and the sex steroid, medroxyprogesterone acetate (MPA) have been shown to have anti-leukaemic properties in other settings. In this study the in vitro efficacy of BEZ and MPA on resting CLL cells (representing resting cells in the periphery) and when stimulated to proliferate by CD40L (representing cells in the PCs) have been investigated. Both BEZ and MPA exerted pro-apoptotic actions against resting CLL cells and reduced CD40L stimulated proliferation. These actions were increased when both agents were combined and demonstrated selectivity against CLL cells compared to normal peripheral blood mononuclear cells. Combined BEZ+MPA, was as effective as the commonly used chemotherapeutic chlorambucil, with the combination of all 3 agents exerting the greatest effects. However none of the combinations induced apoptosis of CLL cells protected by CD40L. Investigations into the possible mechanisms of drug action revealed that MPA was unlikely to be working either by steroid receptors or by inhibition of the enzyme AKR1C3 and the mechanism remains unknown. BEZ alone and in the presence of MPA induced the production of prostaglandin D2 (PGD2) and exogenously applied PGD2 was found to exert apoptosis in a similar manner to BEZ. Both BEZ and MPA generated reactive oxygen species (ROS) in both culture settings and the combination was more effective than either drug alone. In the absence of CD40L, mitochondrial superoxide (MSO) was also produced but not in CD40L stimulated cells. This finding suggested that CD40L is able to prevent or protect against MSO production and, consequently, apoptosis. Attempts at overcoming this effect revealed that the plant derived compound lycorine exerted minimal effects alone but, when combined with BEZ+MPA, reinstated the induction of MSO and recapitulated BEZ+MPA induced apoptosis despite the continual presence of CD40L. In contrast, the reported ability of dasatinib to overcome CD40L mediated fluadarabine resistance was discovered to be to be unfounded." @default.
- W6570133 created "2016-06-24" @default.
- W6570133 creator A5041419381 @default.
- W6570133 date "2010-07-01" @default.
- W6570133 modified "2023-09-23" @default.
- W6570133 title "In Vitro Studies of the Anti-Leukaemic Activity of Bezafibrate and Medroxyprogesterone Acetate Against Chronic Lymphocytic Leukaemia" @default.
- W6570133 cites W125106425 @default.
- W6570133 cites W126934214 @default.
- W6570133 cites W134640083 @default.
- W6570133 cites W1500830863 @default.
- W6570133 cites W1501492534 @default.
- W6570133 cites W1530946604 @default.
- W6570133 cites W1531083786 @default.
- W6570133 cites W159651808 @default.
- W6570133 cites W1636269875 @default.
- W6570133 cites W1782925843 @default.
- W6570133 cites W1789755874 @default.
- W6570133 cites W1833241997 @default.
- W6570133 cites W186437915 @default.
- W6570133 cites W1938426499 @default.
- W6570133 cites W1955442983 @default.
- W6570133 cites W1965475423 @default.
- W6570133 cites W1965570423 @default.
- W6570133 cites W1965667305 @default.
- W6570133 cites W1965851569 @default.
- W6570133 cites W1965986986 @default.
- W6570133 cites W1966037066 @default.
- W6570133 cites W1967777744 @default.
- W6570133 cites W1968354566 @default.
- W6570133 cites W1970446536 @default.
- W6570133 cites W1971163722 @default.
- W6570133 cites W1971344086 @default.
- W6570133 cites W1971487921 @default.
- W6570133 cites W1971595233 @default.
- W6570133 cites W1973557663 @default.
- W6570133 cites W1974536878 @default.
- W6570133 cites W1975082755 @default.
- W6570133 cites W1976088592 @default.
- W6570133 cites W1976951609 @default.
- W6570133 cites W1978235999 @default.
- W6570133 cites W1978520248 @default.
- W6570133 cites W1979273297 @default.
- W6570133 cites W1984634923 @default.
- W6570133 cites W1984917142 @default.
- W6570133 cites W1985561510 @default.
- W6570133 cites W1986786856 @default.
- W6570133 cites W1988315385 @default.
- W6570133 cites W1990826225 @default.
- W6570133 cites W1991050497 @default.
- W6570133 cites W1991586721 @default.
- W6570133 cites W1991988527 @default.
- W6570133 cites W1993986769 @default.
- W6570133 cites W1994381305 @default.
- W6570133 cites W1994740077 @default.
- W6570133 cites W1996985281 @default.
- W6570133 cites W1999292710 @default.
- W6570133 cites W1999555835 @default.
- W6570133 cites W2001825870 @default.
- W6570133 cites W2001850157 @default.
- W6570133 cites W2006344837 @default.
- W6570133 cites W2007289040 @default.
- W6570133 cites W2009593167 @default.
- W6570133 cites W2011972194 @default.
- W6570133 cites W2012112924 @default.
- W6570133 cites W2012251117 @default.
- W6570133 cites W2012743472 @default.
- W6570133 cites W2013064105 @default.
- W6570133 cites W2013115130 @default.
- W6570133 cites W2014631400 @default.
- W6570133 cites W2016191976 @default.
- W6570133 cites W2016973656 @default.
- W6570133 cites W2017547913 @default.
- W6570133 cites W2017692041 @default.
- W6570133 cites W2017898416 @default.
- W6570133 cites W2018728804 @default.
- W6570133 cites W2019274594 @default.
- W6570133 cites W2019685247 @default.
- W6570133 cites W2024363681 @default.
- W6570133 cites W2024884723 @default.
- W6570133 cites W2025185304 @default.
- W6570133 cites W2026368124 @default.
- W6570133 cites W2026792976 @default.
- W6570133 cites W2028164957 @default.
- W6570133 cites W2029903885 @default.
- W6570133 cites W2035918677 @default.
- W6570133 cites W2036114440 @default.
- W6570133 cites W2036333108 @default.
- W6570133 cites W2037031353 @default.
- W6570133 cites W2037355374 @default.
- W6570133 cites W2038067635 @default.
- W6570133 cites W2038476663 @default.
- W6570133 cites W2039175138 @default.
- W6570133 cites W2040591116 @default.
- W6570133 cites W2041726757 @default.
- W6570133 cites W2042393893 @default.
- W6570133 cites W2043688074 @default.
- W6570133 cites W2044236812 @default.
- W6570133 cites W2044391709 @default.
- W6570133 cites W2046283582 @default.
- W6570133 cites W2049686227 @default.